What's new

Human medicines European public assessment report (EPAR): Repaglinide Krka, repaglinide, Date of authorisation: 03/11/2009, Revision: 9, Status: Authorised

Human medicines European public assessment report (EPAR): Repaglinide Krka, repaglinide, Date of authorisation: 03/11/2009, Revision: 9, Status: Authorised

Feb 9, 2025 - 21:46
 0
Human medicines European public assessment report (EPAR): Repaglinide Krka, repaglinide, Date of authorisation: 03/11/2009, Revision: 9, Status: Authorised
Human medicines European public assessment report (EPAR): Repaglinide Krka, repaglinide, Date of authorisation: 03/11/2009, Revision: 9, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Rapamune, sirolimus, D...

Next Article

Questions and answers clinic on post-authorisation procedure management in IRIS,...

Related Posts

EMEA-002904-PIP01-20-M01

EMEA-002904-PIP01-20-M01

Feb 19, 2025  0

Human medicines European public assessment report (EPAR): Lydisilka, estetrol,drospirenone, Date of authorisation: 19/05/2021, Revision: 6, Status: Authorised

Human medicines European public assessment report (EPAR...

Feb 13, 2025  0

Opinion/decision on a Paediatric investigation plan (PIP): Agamree, Vamorolone, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Other, PIP number: P/0515/2023

Opinion/decision on a Paediatric investigation plan (PI...

Feb 14, 2025  0